US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 10.400
  • -0.030-0.29%
Close Feb 14 16:00 ET
  • 10.400
  • 0.0000.00%
Post 20:01 ET
850.43MMarket Cap-1.31P/E (TTM)

About Immunome Company

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Company Profile

SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-939-7410

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Clay B. Siegall,PhD
  • Chief Executive Officer, President and Chairman of the Board
  • 14.87M
  • Kinney Horn
  • Chief Business Officer
  • --
  • Bob Lechleider
  • Chief Medical Officer
  • 2.92M
  • Max Rosett
  • Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
  • --
  • Dr. Jack Higgins, PhD
  • Chief Scientific Officer
  • 1.84M
  • Dr. Bruce Turner, M.D.,PhD
  • Chief Strategy Officer
  • --
  • Sandra G. Stoneman
  • Chief Legal Officer and General Counsel
  • --
  • Dr. Sandra M. Swain, M.D.
  • Director
  • --
  • Philip Wagenheim
  • Director
  • 59.23K
  • Carol A. Schafer
  • Director
  • --
  • Jean-Jacques Bienaime
  • Independent Director
  • 287.93K
  • James P. Boylan, M.B.A.
  • Independent Director
  • 294.75K
  • Isaac Barchas, J.D.
  • Lead Independent Director
  • 296.59K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More